Infliximab for the Treatment of Refractory Kawasaki Disease: A Nationwide Survey in Japan. - Masuda H; Kobayashi T; Hachiya A; Nakashima Y; Shimizu H; Nozawa T; Ogihara Y; Ito S; Takatsuki S; Katsumata N; Suzuki Y; Takenaka S; et al. (The Journal of pediatrics, 2018)